Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.

about

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.

Item

http://www.wikidata.org/entity/Q36108381

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Costs and outcomes associated ...... syndrome in the coverage gap.

@ast

Costs and outcomes associated ...... syndrome in the coverage gap.

@en

type

Item

label

Costs and outcomes associated ...... syndrome in the coverage gap.

@ast

Costs and outcomes associated ...... syndrome in the coverage gap.

@en

prefLabel

Costs and outcomes associated ...... syndrome in the coverage gap.

@ast

Costs and outcomes associated ...... syndrome in the coverage gap.

@en

P1476

Costs and outcomes associated ...... syndrome in the coverage gap.

@en

P2093

Bamrom H Jonathan

http://www.w3.org/2001/XMLSchema#string

Don Beck

http://www.w3.org/2001/XMLSchema#string

Feride Frech-Tamas

http://www.w3.org/2001/XMLSchema#string

Kavita V Nair

http://www.w3.org/2001/XMLSchema#string

Lisa Roper

http://www.w3.org/2001/XMLSchema#string

R Brett McQueen

http://www.w3.org/2001/XMLSchema#string

Richard R Allen

http://www.w3.org/2001/XMLSchema#string

Robert Lee Page

http://www.w3.org/2001/XMLSchema#string

Vahram Ghushchyan

http://www.w3.org/2001/XMLSchema#string

Wing Chan

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of the coverage gap on drug spending: a closer look at Medicare Part D

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interven

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.

The effect of Medicare Part D on drug and medical spending.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD).

P304

67-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DHPS.S32473

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22826644

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

3402012

http://www.w3.org/2001/XMLSchema#string